GI Dynamics Release: EndoBarrier® Therapy to be Featured at Digestive Disease Week 2012
LEXINGTON, Mass. & SYDNEY--(BUSINESS WIRE)--GI Dynamics, Inc. (ASX: GID) announced today that EndoBarrier®Therapy, a breakthrough treatment for type 2 diabetes and/or obesity, will be the subject of several presentations and scientific sessions during Digestive Disease Week 2012 (DDW), taking place May 19-22 at the San Diego Convention Center in San Diego.